Baitianshi

Baitianshi provides a specialized platform for individuals seeking plastic surgery consultations and procedures, connecting patients with accredited medical professionals and hospitals across China. Baitianshi operates a platform focused on plastic surgery insights and consultations. Based in Beijing, China, the company has undergone strategic pivots to enhance its service offerings. The founder has a history of involvement in the healthcare sector, although specific details on previous ventures are not provided.

Baitianshi has participated in 3 deals, with the most recent deal dated March 18, 2021, during which the company filed for bankruptcy. Baitianshi, known as 白天使整形网 (White Angel Plastic Surgery Network), runs a comprehensive platform for plastic surgery consultations. It offers a curated selection of aesthetic procedures, connections to accredited hospitals, and access to esteemed aesthetic professionals. Patients can engage with top medical experts through a live Q&A feature, facilitating informed decisions on cosmetic enhancements.

The platform primarily serves individuals across China, especially in urban areas, ensuring a broad reach. Baitianshi's revenue model emphasizes facilitating direct consultations and educational resources related to plastic surgery. Clients access the platform to connect with healthcare providers, initiating transactions through consultations, referrals, and treatment plans. This B2C model fosters direct interactions with qualified medical professionals.

Revenue generation occurs through partnerships with hospitals and clinics that pay for listings and commissions on referrals, supporting a tailored user experience for clients seeking aesthetic procedures. Following its recent bankruptcy filing on March 18, 2021, Baitianshi is reevaluating its growth strategies. The company will explore opportunities to launch upcoming products focused on enhancing user engagement and education in the plastic surgery field. Future plans include potential expansions into additional cities within China, although specific geographic targets and timelines are not currently available.

The recent funding effort will be crucial in supporting these initiatives as the company aims to stabilize and rebuild.